TRAF6 regulates proliferation, apoptosis, and invasion of osteosarcoma cell

Qingbing Meng1, Minqian Zheng, Hongbing Liu

  • 1Orthopedics Department, Yancheng City No. 1 People's Hospital, 16 Yue-He Road, Yancheng, Jiangsu 224005, People's Republic of China. ycmengqingbing@163.com

Insights

Tumor necrosis factor receptor-associated factor 6 (TRAF6) is overexpressed in osteosarcoma, correlating with tumor progression and metastasis. Reducing TRAF6 expression inhibits osteosarcoma cell invasion and proliferation, suggesting its role in tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • TRAF6 is a key signaling mediator for TNF and IL-1 receptor superfamilies.
  • TRAF6 is implicated in tumorigenesis, invasion, and metastasis.

Purpose of the Study:

  • To investigate TRAF6 expression in osteosarcoma tissues.
  • To correlate TRAF6 expression with clinical pathology and invasion.
  • To explore TRAF6's role in osteosarcoma cell behavior.

Main Methods:

  • RT-PCR and Western blot to assess TRAF6 mRNA and protein expression.
  • RNA interference (siRNA) to down-regulate TRAF6 in MG-63 cells.
  • Transwell assays to evaluate cell invasion and proliferation.
  • Apoptosis assays to measure programmed cell death.

Main Results:

  • TRAF6 mRNA and protein were significantly upregulated in osteosarcoma tissues, especially with lung metastasis and higher Enneking stage.
  • Down-regulation of TRAF6 in MG-63 cells reduced proliferation and invasion, and increased apoptosis.
  • TRAF6 knockdown decreased p-p65, cyclin D1, and MMP-9, while increasing caspase 3 expression.

Conclusions:

  • TRAF6 overexpression is associated with osteosarcoma tumorigenesis and invasion.
  • TRAF6 plays a critical role in regulating osteosarcoma cell proliferation, invasion, and apoptosis.
  • TRAF6 may serve as a potential therapeutic target for osteosarcoma.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...